目的 了解天津市肿瘤医院门诊口服抗肿瘤中成药的使用情况，为促进临床合理使用中成药提供参考。方法 随机抽取天津市肿瘤医院2016年门诊14 381张抗肿瘤相关中成药处方，进行处方点评。结果 683张不合理处方中，60岁以上老年人占50.51%；主要分布于中医科、头颈科、乳腺科、简易门诊、肺科，共占83.90%；紫龙金片、博尔宁胶囊、回生口服液的不合格处方数较多，共占47.14%；按所抽取处方数计算，复方万年青胶囊的不合格率最大，有10种药物的不合格率均小于1%；存在的问题主要为临床诊断不明确、用量超量、适应证不适宜、联合用药不适宜4个方面。结论 天津市肿瘤医院门诊口服抗肿瘤中成药处方不合格率不是很高，但仍存在一定问题，需要采取一些干预措施。

Objective To understand the usage situation of oral antitumor Chinese patent medicines in the outpatient department of Tianjin Tumour Hospital, so as to provide reference for clinical rational use of Chinese patent medicines. Methods Totally 14 381 prescriptions of Chinese patent medicine were randomly selected in Tianjin Tumour Hospital in 2016, and prescription comments were carried out. Results In 683 pieces of unreasonable prescriptions, patients over 60 years old accounted for 50.51%. The unreasonable prescriptions were mainly distributed in Department of traditional Chinese medicine, head and neck, breast, simple outpatient, and lung, accounting for 83.90%. The number of unqualified prescriptions of Zilongjin Tablets, Boerning Capsules, Huisheng Oral Liquid was the most, accounted for 47.14%. According to the selected prescription, the unqualified prescription rate of Compound Wannianqing Capsules was the highest, and the unqualified prescription rate of 10 drugs was less than 1%. The main four aspects of problems were that the clinical diagnosis was not clear, the dose was excessive, the indication was not suitable, and combination was not suitable. Conclusion The unqualified rate of oral antitumor Chinese patent medicines in the outpatient department of Tianjin Tumour Hospital is not very high, but there are still some problems, which needs to take some intervention measures.